METHOD DEVELOPMENT AND VALIDATION FOR IMULTANEOUS ESTIMATION OF HYDROCHLOROTHIAZIDE AND IRBESARTAN BY RP-HPLC Authors: A.Pushpanjali , P. PRACHET, M. SIVA PRASAD AND RAMA RAO N
ABSTRACT
A simple precise, rapid and accurate reverse phase high performance liquid chromatography
method has been developed and validated for the simultaneous estimation of
hydrochlorothiazide and irbesartan. Shimadzu prominence i-series autosampler using
Shimadzu column and separation was achieved with mobile phase acetonitrile: ammonium
acetate (24:76 v/v) at flow rate 0.8 ml/min and wavelength is 290nm. Injection volume was
20 µl with 10min run time. The retention time for hydrochlorothiazide and Irbesartan is 7.488
and 2.746 min respectively. The linearity range for hydrochlorothiazide and irbesartan is 5-25
µg/ml and 6-30 µg/ml with correlation coefficient of 0.999. The %RSD for precision was
found to be 0.93 and 0.92 for Hydrochlorothiazide and Irbesartan and % recovery for
Hydrochlorothiazide and Irbesartan was 100.15 and 100.04 and method was robust. The
developed method was validated according to ICH guidelines. Linearity, Accuracy, %RSD of
precision, LOQ, LOD and robust values were found within the limits and the method was
found to be satisfactory.
Keywords: Hydrochlorothiazide, Irbesartan, RP-HPLC Publication date: 01/02/2022 https://ijbpas.com/pdf/2022/February/MS_IJBPAS_2022_5889.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2022/11.2.5889